TCL Archive ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies June 30, 2006
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: NIEHS to Observe20th Anniversary Dec. 3-5 With Scientific Presentations, Big Celebration November 21, 1986
